← Open Payments lookup

SALEM FITSUM: Open Payments

NPI 1861177131 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,465 in 202 payments from 16 companies in 2025. Trend: 2023 $395 · 2024 $2,676 · 2025 $5,465

Food & beverage: $5,465
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.28$894
Alkermes, Inc.24$808
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$763
ABBVIE INC.29$757
Neurocrine BioSciences, Inc.17$513
Vanda Pharmaceuticals Inc.11$465
E.R. Squibb & Sons, L.L.C.20$449
Janssen Pharmaceuticals, Inc9$190
Supernus Pharmaceuticals, Inc.13$160
Indivior Inc.5$119

Products named: CAPLYTA, VRAYLAR, ARISTADA, REXULTI, INGREZZA, FANAPT, COBENFY, ABILIFY ASIMTUFII.

Industry payments across NV — which companies pay providers there.